MXELOXIRI Combined With Molecular Targeting Drug as First-line Therapy in Patients With Initially Unresectable Metastatic Colorectal Cancer: A Phase II, Single-arm, Prospective Clinical Study

ABSTRACT: Interventions: Case series:mXELOXIRI Combined With Molecular Targeting Drug Primary outcome(s): Objective response rate Study Design: Single arm

DISEASE(S): Initially Unresectable Metastatic Colorectal Cancer

PROVIDER: 2684302 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR